Schaefer, Martin <br/><br/>
Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Oct 2007 
 - 991-8 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0270-9139 
<br/><br/><label>Standard No.: </label>10.1002/hep.21791  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antidepressive Agents--therapeutic use<br/>Antiviral Agents--adverse effects<br/>Depression--chemically induced<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--adverse effects<br/>Logistic Models<br/>Male<br/>Mental Disorders--complications<br/>Middle Aged<br/>Polyethylene Glycols--adverse effects<br/>Prospective Studies<br/>Recombinant Proteins<br/>Ribavirin--adverse effects<br/>Risk Factors<br/>Substance-Related Disorders--complications<br/>Treatment Outcome